Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JCAP
JCAP logo

JCAP Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Jefferson Capital Inc (JCAP) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
19.300
1 Day change
-0.82%
52 Week Range
23.800
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Jefferson Capital Inc (JCAP) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has strong financial growth, positive analyst sentiment, and a favorable industry position. Despite no immediate trading signals, its strong fundamentals and growth potential make it a solid long-term investment.

Technical Analysis

The MACD is below 0 and negatively contracting, indicating a weak bearish trend. RSI is neutral at 43.154, and moving averages are converging, suggesting no clear trend. The stock is trading near its support level (S1: 19.189) with resistance at R1: 21.665.

Positive Catalysts

  • Record Q4 2025 earnings with a 30% YoY revenue increase.

  • Projected $1.1 billion receivables collection over the next 12 months.

  • Analysts maintain positive ratings with price targets as high as $28, indicating strong growth potential.

  • Industry-leading cash efficiency ratio and consistent operating results.

Neutral/Negative Catalysts

  • Rising legal channel costs ($17.7 million in Q4 2025).

  • EPS dropped to 0 in Q4 2025, down 100% YoY.

Financial Performance

In Q4 2025, Jefferson Capital reported a 20.94% YoY revenue increase to $101.5 million and a 39.99% YoY net income increase to $37.7 million. However, EPS dropped to 0, reflecting potential short-term challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are generally positive on JCAP. Raymond James lowered its price target to $22 but maintains an Outperform rating, citing strong fundamentals. Texas Capital and Keefe Bruyette both have Buy ratings with price targets of $28, highlighting attractive valuation, consistent results, and industry leadership.

Wall Street analysts forecast JCAP stock price to rise
4 Analyst Rating
Wall Street analysts forecast JCAP stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 19.300
sliders
Low
26
Averages
27.25
High
29
Current: 19.300
sliders
Low
26
Averages
27.25
High
29
Raymond James
Outperform
downgrade
$25 -> $22
AI Analysis
2026-03-13
Reason
Raymond James
Price Target
$25 -> $22
AI Analysis
2026-03-13
downgrade
Outperform
Reason
Raymond James lowered the firm's price target on Jefferson Capital to $22 from $25 and keeps an Outperform rating on the shares. Despite reducing its price target, the firm continues to believe Jefferson's lower leverage, efficient collection model, heavy exposure to the U.S. market, which the firm believes is "currently more attractive," and recent acquisition of Blue Stem "position Jefferson Capital to outperform in the medium term."
Texas Capital
NULL
to
Buy
initiated
$28
2026-02-10
Reason
Texas Capital
Price Target
$28
2026-02-10
initiated
NULL
to
Buy
Reason
Texas Capital initiated coverage of Jefferson Capital with a Buy rating and $28 price target, which implies 29% total return when including the dividend. Jefferson is a technology enabled buyer and processor of charged-off, insolvency, and active consumer receivables, the analyst tells investors in a research note. The firm says the company has reported more consistent operating results relative to peers. It sees an attractive valuation given Jefferson's "high margin franchise."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for JCAP
Unlock Now

People Also Watch